Evidence-based lists covering every corner of perimenopause and menopause — because you deserve clear answers, not a wall of text.
43 lists and countingSERMs offer tissue-specific estrogen activity without systemic estrogen. Here's what women in perimenopause and menopause need to know about how they work.
Ospemifene treats vaginal dryness and painful sex without estrogen. Here's what women need to know about how it works, who it's for, and what to expect.
HRT does more than reduce wrinkles. Here's what the research actually says about collagen, wound healing, skin barrier, and sebaceous gland function.
The timing hypothesis explains why starting HRT early in menopause may protect your heart and brain — and why later initiation carries different risks.
Vaginal estrogen is safe, effective, and underused. Here are 11 evidence-backed facts that clear up the fears stopping women from getting real relief.
CBT-I outperforms sleep medications for menopause insomnia long-term. Here's the clinical case for it — and the practical ways to actually access it.
Fezolinetant targets hot flashes differently than any drug before it. Here's what the science actually says about how it works, who it helps, and what it costs.
Starting HRT early in menopause offers dramatically stronger bone protection than starting later. Here's the specific timing data most women never hear.
Oral vs transdermal estrogen aren't interchangeable. The delivery route changes clot risk, liver load, triglycerides, and more in ways that matter.
The fear around vaginal estrogen is real but not evidence-based. Here are 9 facts that give women an accurate, calm safety picture.
The evidence linking estrogen to fracture prevention is stronger than most women are told. Here are 11 precise facts that change how you think about HRT and bone health.
Oral vs transdermal HRT carries very different blood clot risks. Here's what the evidence actually says — and why delivery route changes everything.
HRT timing, dose, route and duration each affect bone protection differently. Here's what the research actually shows about fracture risk reduction.
Fezolinetant (Veoza) works on brain chemistry, not hormones. Here's what the trial data actually show about this new non-hormonal hot flash treatment.
New data from KEEPS and ELITE trials reveals what the WHI missed about HRT and cardiovascular protection — including the critical age window that changes everything.
Progesterone cream and oral micronized progesterone are not interchangeable. Here are 9 evidence-based differences every woman in perimenopause should understand.
Oral vs transdermal HRT carries very different clot risks. Here are 9 evidence-based facts every woman on or considering HRT needs to understand.
Patches, gels, and sprays deliver estrogen differently. Here's what that means for absorption, dosing, skin sensitivity, and finding what actually works for you.
HRT and hypertension drugs can interact in ways most doctors never mention. Here's what women managing both conditions need to know.
SERMs offer a middle ground between HRT and doing nothing. Here's what women need to know about how they work, what they help, and their real limits.
Gel, patch, or spray? Here are 9 real-world differences that help women starting transdermal estrogen HRT choose the right format for their life.
Stellate ganglion block is a nerve injection showing real results for severe hot flashes — especially for women who can't use hormones. Here's what to know.
Testosterone isn't just a male hormone. Here are 11 evidence-based facts every woman in menopause should know about testosterone therapy.
Low-dose naltrexone is being explored for hot flashes, pain, and mood in menopause. Here's what the evidence actually says about this under-discussed option.